Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05913609 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia
A NA study of Shoulder Dystocia, sponsored by FetalEase.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 4
- Study locations
NCT05913609: Recruiting NA study of Shoulder Dystocia, sponsored by FetalEase.
NCT05913609 is a NA study of Shoulder Dystocia that is actively recruiting participants, run by FetalEase. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05913609, a NA study of Shoulder Dystocia, is actively recruiting participants, sponsored by FetalEase.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 4
- Study locations
Study Summary
Prospective, multi-center, single arm with historical control, to verify the safety and effectiveness of the Yaari Extractor used by board certified or board eligible U.S. OB/GYN physicians in the management of shoulder dystocia.
Primary Outcome
First Primary Effectiveness Endpoint
Conditions Studied
Interventions
- DEVICE Yaari Extractor
Study Locations (4)
Florida
- University of Miami - Jackson Memorial - Miami
Idaho
- Rosemark WomenCare Specialist - Idaho Falls
North Carolina
- Unified Women's Clinical Research - Winston-Salem
Virginia
- Inova Fairfax Medical Campus - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-11-15 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT05913609 shows while recruiting
NCT05913609 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Shoulder Dystocia appearing as the primary indexed condition, and to 1 intervention - of which Yaari Extractor is the first listed.
NCT05913609 reports a single indexed study location in Florida, Idaho, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05913609 about?
NCT05913609 is a clinical study titled "Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia". Prospective, multi-center, single arm with historical control, to verify the safety and effectiveness of the Yaari Extractor used by board certified or board eligible U.S. OB/GYN physicians in the management of shoulder dystocia.
What is the current status of trial NCT05913609?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-11-15. Estimated completion is 2027-04.
What conditions does trial NCT05913609 study?
This clinical trial studies the following conditions: Shoulder Dystocia.
What interventions are being tested in trial NCT05913609?
The interventions under investigation include: Yaari Extractor (DEVICE).
Who is sponsoring clinical trial NCT05913609?
This trial is sponsored by FetalEase, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05913609 being conducted?
This trial has 4 study locations across Florida, Idaho, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05913609's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI